NL950027I2 - Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them. - Google Patents

Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.

Info

Publication number
NL950027I2
NL950027I2 NL950027C NL950027C NL950027I2 NL 950027 I2 NL950027 I2 NL 950027I2 NL 950027 C NL950027 C NL 950027C NL 950027 C NL950027 C NL 950027C NL 950027 I2 NL950027 I2 NL 950027I2
Authority
NL
Netherlands
Prior art keywords
alpha
halomethyl
amino acid
acid derivatives
pharmaceutical preparation
Prior art date
Application number
NL950027C
Other languages
Dutch (nl)
Other versions
NL950027I1 (en
Original Assignee
Marion Merrell Et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Et Cie filed Critical Marion Merrell Et Cie
Publication of NL950027I1 publication Critical patent/NL950027I1/en
Publication of NL950027I2 publication Critical patent/NL950027I2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NL950027C 1977-07-11 1995-11-17 Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them. NL950027I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81476577A 1977-07-11 1977-07-11
US2875779A 1979-04-10 1979-04-10
US2875879A 1979-04-10 1979-04-10

Publications (2)

Publication Number Publication Date
NL950027I1 NL950027I1 (en) 1996-02-01
NL950027I2 true NL950027I2 (en) 1997-06-02

Family

ID=27363337

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7807453A NL190662C (en) 1977-07-11 1978-07-11 alpha-Halo-methyl-alpha-amino acid derivatives and pharmaceutical composition containing them.
NL950027C NL950027I2 (en) 1977-07-11 1995-11-17 Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL7807453A NL190662C (en) 1977-07-11 1978-07-11 alpha-Halo-methyl-alpha-amino acid derivatives and pharmaceutical composition containing them.

Country Status (9)

Country Link
JP (1) JPS5419913A (en)
AU (1) AU522660B2 (en)
BE (3) BE868882A (en)
CA (1) CA1091661A (en)
CH (1) CH642055A5 (en)
DE (1) DE2828739A1 (en)
FR (1) FR2430418A1 (en)
GB (1) GB2001960B (en)
NL (2) NL190662C (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197394A (en) * 1980-06-16 1984-09-28 Merrell Dow Pharma Inhibition of protozoal growth in animals with certain-substituted-amines or amino acids
US4399151A (en) 1980-06-16 1983-08-16 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the growth of protozoa
ZA815808B (en) * 1980-08-23 1982-08-25 Merrell Toraude & Co Fluorinated pentene diamine derivatives
GB2083030B (en) * 1980-08-23 1984-03-07 Merrell Toraude & Co Fluorinated pentene diamine derivatives
US4437873A (en) 1981-03-23 1984-03-20 Merrell Dow Pharmaceuticals Inc. Method of inhibiting algae
US4423073A (en) * 1981-08-19 1983-12-27 Merrell Toraude Et Compagnie Fluorinated diaminopentene derivatives
US4446151A (en) * 1981-08-19 1984-05-01 Merrell Toraude Et Compagnie Decarboxylase-inhibiting fluorinated pentane diamine derivatives
US4435425A (en) 1982-04-09 1984-03-06 Merrell Toraude Et Compagnie Fluorinated diaminobutane derivatives
JPS62148462A (en) * 1985-12-19 1987-07-02 メレルダウフア−マス−テイカルズ　インコ−ポレ−テツド Novel method of controlling growth of protozoa
ATE77367T1 (en) * 1988-02-05 1992-07-15 Merrell Dow Pharma 5-SUBSTITUTED ORNITHINE DERIVATIVES.
CA1319123C (en) * 1988-08-31 1993-06-15 Andrew T. Au Method for the production of (-) 2-substituted-ornithines
US6187296B1 (en) 1998-01-23 2001-02-13 The Board Of Regents Of The University Of Oklahoma Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US6103220A (en) * 1998-01-23 2000-08-15 Levine; Martin Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2392958A1 (en) * 1977-06-01 1978-12-29 Merck & Co Inc NEW FLUORINE AMINO ACIDS USEFUL AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
BE881208A (en) 1980-05-16
GB2001960A (en) 1979-02-14
FR2430418B1 (en) 1984-07-13
JPH0122259B2 (en) 1989-04-25
CA1091661A (en) 1980-12-16
BE881209A (en) 1980-05-16
DE2828739A1 (en) 1979-02-01
NL190662C (en) 1994-06-16
NL7807453A (en) 1979-01-15
FR2430418A1 (en) 1980-02-01
CH642055A5 (en) 1984-03-30
BE868882A (en) 1978-11-03
NL950027I1 (en) 1996-02-01
JPS5419913A (en) 1979-02-15
GB2001960B (en) 1982-02-24
AU522660B2 (en) 1982-06-17
NL190662B (en) 1994-01-17
AU3732778A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
NL7801187A (en) PHARMACEUTICAL TABLET.
NL7808125A (en) PHARMACEUTICAL PREPARATIONS OF ALUMINUM SALTS OF IBUPROPHENE.
DK541878A (en) PHTHALAZINE-4-YLEDICIC ACID DERIVATIVES
NL190519B (en) 4-SUBSTITUTED PHENYLACACIC ACID COMPOUNDS, AND PHARMACEUTICAL PREPARATIONS.
BE871584A (en) PHARMACEUTICAL PREPARATIONS
NL7811692A (en) PHENYLGLYCIN DERIVATIVES AND PREPARATIONS CONTAINING THEM.
NL950027I1 (en) Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.
NL190520B (en) PLACE 1 SUBSTITUTED, 7-SUBSTITUTED AMINO-6-HALOGEN-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBONIC ACIDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
SE7809373L (en) PHARMACEUTICAL USE 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE DERIVATIVES
NL188645C (en) 1-AZAXANTHON-3-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL7711446A (en) PHARMACEUTICAL DISINFECTING PREPARATION.
NL7806528A (en) PREPARATION OF SALPETERIC ACID.
NO147437C (en) PARTICULAR SUBSTANCE FOR DRUGS.
IT7821686A0 (en) PHARMACEUTICAL COMPOSITION.
NL7900264A (en) 4-PYRIDONE-3-CARBONIC ACID DERIVATIVES AND THEIR PREPARATION.
NL192870B (en) Anti-hypertensive oral pharmaceutical preparation.
NL7801921A (en) PHARMACEUTICAL PREPARATIONS.
NL7804887A (en) BISAMIDINE COMPOUNDS, THEIR PREPARATION, AND PHARMACEUTICAL MIXTURES CONTAINING THEM.
IT7825570A0 (en) ANTICANCER SUBSTANCE AND PROCEDURE FOR ITS PREPARATION.
NL7807871A (en) ALPHA-HALOGEN METHYLAMINOIC ACID DERIVATIVES.
NL184896C (en) PYRANOCHINOLIN DERIVATIVES AND FORMED PHARMACEUTICAL PREPARATIONS CONTAINING THESE.
FI783049A (en) PHARMACEUTICAL ACTIVE (OMEGA-AMINOALCOXY) DIBENZYLER
NL7808440A (en) ANTI-INFLAMMATORY 1-PHENYLETHANOLAMINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND METHODS FOR PREPARATION THEREOF.
NL7801576A (en) BENZOHETEROCYCLYLGLYOXYL ACID DERIVATIVES.
NL7805158A (en) PHARMACEUTICAL PREPARATION.